{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:42:02Z","timestamp":1720550522179},"reference-count":22,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":274,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/cei.12533","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T12:43:26Z","timestamp":1419857006000},"page":"112-114","source":"Crossref","is-referenced-by-count":2,"special_numbering":"supplement S1","title":["7<sup>th<\/sup>International Immunoglobulin Conference: Immunomodulation"],"prefix":"10.1093","volume":"178","author":[{"given":"M. G.","family":"Danieli","sequence":"first","affiliation":[{"name":"Universit\u00e0 Politecnica delle Marche; Ancona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Shoenfeld","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; Tel-Aviv University; Tel-Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"10.1111\/cei.12533-BIB0001|cei12533-cit-0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0897.1996.tb00495.x","article-title":"Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions","volume":"35","author":"Kwak","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/cei.12533-BIB0002|cei12533-cit-0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0897.2012.01135.x","article-title":"Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells","volume":"68","author":"Moraru","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/cei.12533-BIB0003|cei12533-cit-0003","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0897.2005.00356.x","article-title":"High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins","volume":"55","author":"Perricone","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/cei.12533-BIB0004|cei12533-cit-0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/clin.1994.1091","article-title":"Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules","volume":"71","author":"Rigal","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1111\/cei.12533-BIB0005|cei12533-cit-0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0897.2007.00473.x","article-title":"Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G","volume":"57","author":"Roussev","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/cei.12533-BIB0006|cei12533-cit-0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0897.1996.tb00496.x","article-title":"Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion","volume":"35","author":"Ruiz","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/cei.12533-BIB0007|cei12533-cit-0007","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0008|cei12533-cit-0008","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.autrev.2014.08.023","article-title":"Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study","volume":"13","author":"Danieli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0009|cei12533-cit-0009","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.autrev.2012.10.015","article-title":"Complex regional pain syndrome, prototype of a novel kind of autoimmune disease","volume":"12","author":"Goebel","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0010|cei12533-cit-0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2014.01.026","article-title":"Diagnosis and classification of immune-mediated thrombocytopenia","volume":"13","author":"Lo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0011|cei12533-cit-0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.autrev.2012.04.006","article-title":"Intravenous immunoglobulin for the treatment of Crohn's disease","volume":"12","author":"Rogosnitzky","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0012|cei12533-cit-0012","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.autrev.2013.01.002","article-title":"A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro\/La-related congenital atrioventricular block. A case series and review of the literature","volume":"12","author":"Ruffatti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0013|cei12533-cit-0013","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2013.02.002","article-title":"Biotherapies in inflammatory ocular disorders: interferons, immunoglobulins, monoclonal antibodies","volume":"12","author":"Saadoun","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0014|cei12533-cit-0014","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","article-title":"Tregitope update: mechanism of action parallels IVIg","volume":"12","author":"Cousens","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0015|cei12533-cit-0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0016|cei12533-cit-0016","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","article-title":"Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis","volume":"9","author":"Danieli","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0017|cei12533-cit-0017","first-page":"s128","article-title":"Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis","volume":"20","author":"Gibofsky","year":"2014","journal-title":"Am J Manag Care"},{"key":"10.1111\/cei.12533-BIB0018|cei12533-cit-0018","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","article-title":"Different effects of biological drugs in rheumatoid arthritis","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0019|cei12533-cit-0019","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2011.05.017","article-title":"Autoimmune blistering diseases of the skin","volume":"11","author":"Sticherling","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0020|cei12533-cit-0020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","article-title":"Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies","volume":"12","author":"Comarmond","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1111\/cei.12533-BIB0021|cei12533-cit-0021","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/humrep\/der185","article-title":"Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: methodological problems","volume":"26","author":"Clark","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1111\/cei.12533-BIB0022|cei12533-cit-0022","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-0528.2006.01201.x","article-title":"Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review","volume":"114","author":"Hutton","year":"2007","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Clinical &amp; Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12533","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/cei.12533\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:27:28Z","timestamp":1641054448000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cei.12533"}},"subtitle":["Immunomodulation"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1111\/cei.12533","archive":["Portico"],"relation":{},"ISSN":["0009-9104"],"issn-type":[{"value":"0009-9104","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}